The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 22, 2018

Filed:

Jun. 27, 2014
Applicants:

David A. Scheinberg, New York, NY (US);

Michael R. Mcdevitt, Bronx, NY (US);

Carlos H. Villa, Philadelphia, PA (US);

J. Justin Mulvey, New York, NY (US);

Inventors:

David A. Scheinberg, New York, NY (US);

Michael R. McDevitt, Bronx, NY (US);

Carlos H. Villa, Philadelphia, PA (US);

J. Justin Mulvey, New York, NY (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/00 (2006.01); A61M 36/14 (2006.01); C12N 15/113 (2010.01); A61K 51/12 (2006.01); A61K 51/10 (2006.01); C12N 15/11 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 47/68 (2017.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 47/6849 (2017.08); A61K 51/1027 (2013.01); A61K 51/1093 (2013.01); A61K 51/1203 (2013.01); A61K 51/1248 (2013.01); C07K 16/2803 (2013.01); C07K 16/2887 (2013.01); C07K 16/30 (2013.01); C12N 15/111 (2013.01); B82Y 5/00 (2013.01); C07K 2317/92 (2013.01); C12N 2310/113 (2013.01); C12N 2310/3233 (2013.01); C12N 2310/351 (2013.01); C12N 2320/32 (2013.01); Y10S 977/75 (2013.01); Y10S 977/842 (2013.01); Y10S 977/906 (2013.01);
Abstract

Provided herein are methods for delivering a molecule in situ to a cell and for treating a cancer via the in situ delivery. The methods comprise contacting or administering to the cell, as two separate components, a morpholino oligonucleotide comprising a targeting moiety followed by a single wall nanotube construct comprising second morpholino oligonucleotides complementary to the first morpholino oligonucleotides and one or both of a therapeutic or diagnostic payload molecule linked to the single wall nanotube construct. Upon self-assembly of a single wall nanotube complex via hybridization of the first morpholino and second complementary morpholino oligonucleotides at the cell, the payload molecule is delivered. Also provided is the two component self-assembly single wall nanotube system and the single wall nanotube construct comprising the second component.


Find Patent Forward Citations

Loading…